Skip to main content

Two Bausch Health Companies Inc. directors bought the dip after the company released second-quarter results in August. On Aug. 4, Richard Urbain De Schutter bought 10,000 shares. He now holds 294,657 shares. The next day, Andrew Charles von Eschenbach bought 1,400 shares. The stock subsequently rose as much as 15 per cent but has since cooled off. Bausch is looking to split into three distinct companies with the separation process expected to start as market conditions permit. Meanwhile, third-quarter earnings are scheduled to be released on Nov. 2.


Ted Dixon is CEO of INK Research which provides insider news and knowledge to investors. For more background on insider reporting in Canada, visit the FAQ section at Securities referenced in this profile may have already appeared in recent reports distributed to INK subscribers. INK staff may also hold a position in profiled securities.

Chart reflects public-market transactions of common shares or unit trusts by company officers and directors.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Report an error

Editorial code of conduct

Tickers mentioned in this story